HBV
Clinical trials for HBV explained in plain language.
Never miss a new study
Get alerted when new HBV trials appear
Sign up with your email to follow new studies for HBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hepatitis b drug enters human testing phase
Disease control Recruiting nowThis early-stage trial is testing a new drug called Tune-401 in adults with chronic hepatitis B. The main goal is to check if the drug is safe and how the body processes it. Researchers will also measure how it affects the hepatitis B virus in participants who are already taking …
Matched conditions: HBV
Phase: PHASE1 • Sponsor: Tune Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
One test, four diseases: new device aims to simplify screening in africa
Diagnosis Recruiting nowThis study is evaluating a new point-of-care medical device called MagIA H3S. The device is designed to screen for four major infections—HIV, hepatitis B, hepatitis C, and syphilis—from a single blood sample. Researchers in Ivory Coast and Kenya will test its accuracy compared to…
Matched conditions: HBV
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
New blood test could unlock better treatment for stubborn liver viruses
Knowledge-focused Recruiting nowThis study aims to develop a faster blood test that measures the immune system's response in people with chronic hepatitis B and D. Researchers will observe 300 patients over time to see how their immune cells relate to their disease status and treatment outcomes. The goal is to …
Matched conditions: HBV
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Scientists probe Gut-Liver link in hepatitis d treatment
Knowledge-focused Recruiting nowThis study aims to understand how a hepatitis D treatment called bulevirtide affects gut bacteria and bile acids in patients. Researchers will follow 20 patients with hepatitis D and liver damage, collecting samples over 48 weeks to see how these gut factors change during treatme…
Matched conditions: HBV
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC